BIOMAT Database Logo BIOMAT Database Logo

Bone Marrow Plasma Cytokine Signature Profiles in Severe Aplastic Anemia. 2020

Bingnan Liu, and Yuanyuan Shao, and Zixuan Liu, and Chunyan Liu, and Tian Zhang, and Rong Fu
Department of Hematology, Tianjin Medical University General Hospital, 154 Anshan Street, Heping District, Tianjin 300052, China.

OBJECTIVE We studied bone marrow plasma (BMP) cytokines in severe aplastic anemia (SAA) patients and healthy volunteers to investigate differences in the cytokine profiles between them and propose a cytokine signature of SAA. METHODS A Bio-Plex suspension array system was used to measure 27 analytes in BMP samples from 47 SAA patients and 30 healthy donors. RESULTS Compared to healthy people, SAA patients had higher levels of tumor necrosis factor α (TNF-α (TNF-γ (IFN-γ (IFN-β (MIP-1β (MIP-1α (TNF-α (TNF-β (MIP-1β (MIP-1β (MIP-1γ (IFN-α (TNF. CONCLUSIONS The current study demonstrated distinct cytokine profiles among untreated SAA patients, recovering SAA (RSAA) patients, and healthy people. The cytokines of RSAA patients showed similar characteristics to those of untreated SAA patients and healthy people, respectively, which may reflect that the immune status of RSAA patients is in different stages of recovery after IST; thus, it may provide an important tool in diagnosing and evaluating or predicting curative effects in clinics.

UI MeSH Term Description Entries
D008233 Lymphotoxin-alpha A tumor necrosis factor family member that is released by activated LYMPHOCYTES. Soluble lymphotoxin is specific for TUMOR NECROSIS FACTOR RECEPTOR TYPE I; TUMOR NECROSIS FACTOR RECEPTOR TYPE II; and TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 14. Lymphotoxin-alpha can form a membrane-bound heterodimer with LYMPHOTOXIN-BETA that has specificity for the LYMPHOTOXIN BETA RECEPTOR. TNF Superfamily, Member 1,TNF-beta,Tumor Necrosis Factor Ligand Superfamily Member 1,Tumor Necrosis Factor-beta,Lymphotoxin,Lymphotoxin-alpha3,Soluble Lymphotoxin-alpha,alpha-Lymphotoxin,Lymphotoxin alpha,Lymphotoxin alpha3,Lymphotoxin-alpha, Soluble,Soluble Lymphotoxin alpha,Tumor Necrosis Factor beta,alpha Lymphotoxin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Bingnan Liu, and Yuanyuan Shao, and Zixuan Liu, and Chunyan Liu, and Tian Zhang, and Rong Fu
Retracted: Bone Marrow Plasma Cytokine Signature Profiles in Severe Aplastic Anemia.
January 2024, BioMed research international,
Bingnan Liu, and Yuanyuan Shao, and Zixuan Liu, and Chunyan Liu, and Tian Zhang, and Rong Fu
Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.
April 2011, Haematologica,
Bingnan Liu, and Yuanyuan Shao, and Zixuan Liu, and Chunyan Liu, and Tian Zhang, and Rong Fu
[Bone marrow transplantation in severe aplastic anemia].
December 1977, Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg,
Bingnan Liu, and Yuanyuan Shao, and Zixuan Liu, and Chunyan Liu, and Tian Zhang, and Rong Fu
[Bone marrow transplantation in severe aplastic anemia].
April 1986, Deutsche medizinische Wochenschrift (1946),
Bingnan Liu, and Yuanyuan Shao, and Zixuan Liu, and Chunyan Liu, and Tian Zhang, and Rong Fu
Bone marrow transplantation for severe aplastic anemia.
December 1993, Journal of the Formosan Medical Association = Taiwan yi zhi,
Bingnan Liu, and Yuanyuan Shao, and Zixuan Liu, and Chunyan Liu, and Tian Zhang, and Rong Fu
[Bone marrow transplantation for severe aplastic anemia].
January 1998, Medicina,
Bingnan Liu, and Yuanyuan Shao, and Zixuan Liu, and Chunyan Liu, and Tian Zhang, and Rong Fu
Bone marrow transplantation for severe aplastic anemia.
August 1991, Bone marrow transplantation,
Bingnan Liu, and Yuanyuan Shao, and Zixuan Liu, and Chunyan Liu, and Tian Zhang, and Rong Fu
Bone marrow transplantation for acquired severe aplastic anemia.
December 2014, Hematology/oncology clinics of North America,
Bingnan Liu, and Yuanyuan Shao, and Zixuan Liu, and Chunyan Liu, and Tian Zhang, and Rong Fu
Allogeneic bone marrow transplantation for severe aplastic anemia.
October 1991, Seminars in hematology,
Bingnan Liu, and Yuanyuan Shao, and Zixuan Liu, and Chunyan Liu, and Tian Zhang, and Rong Fu
HLA-mismatched bone marrow transplantation in severe aplastic anemia.
September 2017, Bone marrow transplantation,
Copied contents to your clipboard!